High-throughput tissue microarray analysis of GI -cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin EI

Journal of Pathology

Volumn 199, Issue 2, 2003, Pages 201-207

  Tzankov, Alexander ^a   Zimpfer, Annette ^a,b   Lugli, Alessandro ^b   Krugmann, Jens ^a   Went, Philip ^b   Schraml, Peter ^b   Maurer, Robert ^c   Ascani, Stefano ^d   Pileri, Stefano ^d   Geley, Stephan ^a   Dimhofer, Stephan ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cyclin E; Epstein Barr virus; G1 cyclins; Hodgkin's lymphoma; Tissue microarray

Indexed keywords

CYCLIN E; CYCLINE; LATENT MEMBRANE PROTEIN 1;

ANALYTIC METHOD; ARTICLE; CANCER TISSUE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DUPLICATE GENE; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE TECHNOLOGY; GENETIC ANALYSIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; REGULATORY MECHANISM; RELIABILITY; TISSUE SECTION;

CYCLIN E; CYCLINS; GENE AMPLIFICATION; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PROTEIN ARRAY ANALYSIS; VIRAL MATRIX PROTEINS;

EID: 0037314550     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1279     Document Type: Article

References (30)

1. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-1677.
2. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000; 60: 3689-3695.
3. Gillett CE, Barnes DM. Demystified ... cell cycle. J Clin Pathol 1998; 51: 310-316.
4. Bartek J, Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 2001; 490: 117-122.
5. Morgan DO. Principles of CDK regulation. Nature 1995; 374: 131-134.
6. Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas - prognostic implications. Blood 1998; 92: 770-777.
7. Nakamura S, Yatabe Y, Seto M. Cyclin D1 overexpression in malignant lymphoma. Pathol Int 1997; 47: 421-429.
8. Møller MB, Nielsen O, Pedersen NT. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features. Am J Clin Pathol 2001; 115: 404-412.
9. Kaelin WG. Recent insights into the functions of the retinoblastoma susceptibility gene product. Cancer Invest 1997; 15: 243-254.
10. Ohtsubo M, Theodoras AM, Schumacher J, Roberts J, Pagano M. Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol Cell Biol 1995; 15: 2612-2624.
11. Sauer K, Lehner CF. The role of cyclin E in the regulation of entry into S phase. Prog Cell Cycle Res 1995; 1: 125-139.
12. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999; 401: 297-300.
13. cdc2 and cyclin B-1. Int J Cancer 1998; 77: 408-414.
14. Spina D, Leoncini L, Close P, et al. Growth vs. DNA strand breaks in Hodgkin's disease: impaired proliferative ability of Hodgkin and Reed-Sternberg cells. Int J Cancer 1996; 66: 179-183.
15. Schmid C, Sweeney E, Isaacson PG. Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease. J Pathol 1992; 168: 1-6.
16. Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-Re1A activation is required for proliferation and survival of Hodgkin's disease tumour cells. J Clin Invest 1997; 100: 2961-2969.
17. Kanavaros P, Stefanaki K, Vlachonikolis J, et al. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas. Histol Histapathol 2000; 15: 445-453.
18. Ohshima K, Haraoka S, Fujiki T, et al. Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression. Pathol Int 1999; 49: 506-512.
19. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of hundreds of specimens. Nature Med 1998; 4: 844-847.
20. Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumour types. Clin Cancer Res 1999; 5: 1966-1975.
21. Stein H, Delsol G, Pileri S, et al. Classical Hodgkin lymphoma. In Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid System, Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). IARC Press: Lyon, 2001; 244-253.
22. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 1999; 30: 781-787.
23. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88: 4766-4770.
24. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nature Med 2002; 8: 68-74.
25. Hollyoake M, Stuhler A, Farrell P, Gordon J, Sinclair A. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus. Cancer Res 1995; 55: 4784-4787.
26. Bresnahan WA, Boldogh I, Ma T, Albrecht T, Thompson EA. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ 1996; 7: 1283-1290.
27. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 2001; 413: 311-316.
28. D'Angiolella V, Costanzo V, Gottesman ME, Avvedimento EV, Gautier J, Grieco D. Role for cyclin-dependent kinase 2 in mitosis exit. Curr Biol 2001; 11: 1221-1226.
29. Mumberg D, Haas K, Moroy T, et al. Uncoupling of DNA replication and cell cycle progression by human cyclin E. Oncogene 1996; 13: 2493-2497.
30. den Elzen N, Pines J. Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J Cell Biol 2001; 153: 121-136.